 KalVista Pharmaceuticals, Inc. NASDAQ: KALV, a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, today announced that it will present at the SVB Leerink 9th Annual Global Healthcare Conference on Tuesday, February 25, 2020, at 2:30 p.m. ET in New York, NY. 